Implementation of an ePRO Application for Health-Related Quality of Life (HrQoL) in Breast Cancer Patients: Evaluation and Usability Analysis (Preprint)

2019 ◽  
Author(s):  
Joachim Graf ◽  
Nina Sickenberger ◽  
Katharina Brusniak ◽  
Lina Matthies ◽  
Thomas M. Deutsch ◽  
...  

BACKGROUND One in eight women is diagnosed with breast cancer in the course of her life. As systematic palliative treatment has an only limited effect on survival rates, the concept of Health-related Quality of Life (HRQoL). Various studies have already demonstrated the reliability of paper-based PRO (pPRO) and ePRO and that the two means of assessment are equally valid. OBJECTIVE The aim of this study was to analyze the acceptance and evaluation of a tablet-based ePRO applica-tion for breast cancer patients and to examine its suitability, effort, and difficulty in the context of HRQoL and sociodemographic factors. METHODS In all, 106 women with adjuvant or advanced breast cancer were included in a two-center study at two major university hospitals in Germany. Patients were asked to answer HRQoL (EORTC QLQ-C 30, FACT-B) and PRO questionnaires both on a tablet on-site using a specific eHealth assessment website and on paper. The suitability, effort, and difficulty of the application and self-reported technical skills were also assessed. Only the results of the electronically acquired data are presented here, results of reliability to pPRO data have already been published elsewhere. RESULTS Patients regarded the ePRO assessment as more suitable (74.8%), less stressful (69.8%), and less difficult than pPRO (65.2%). The majority of patients stated that ePRO improves health care in hospitals (82.1%). However, evaluation of ePRO depends on the level of education (p=0.003) and patients’ experience in using a computer (p=0.041). The application was rated highly in all categories. HRQoL data did not show significant correlations to the application’s evaluation parameters. CONCLUSIONS The results indicate that ePRO surveys are also feasible for measuring HRQoL in breast cancer pa-tients and that those patients prefer ePRO to pPRO assessment. It can also be seen that patients consider ePRO to be improve hospital health care. However, studies with larger numbers of patients are needed to develop applications that address the needs of patients with lower levels of education and technical skills.

2019 ◽  
Vol 17 (1) ◽  
Author(s):  
Diriba Alemayehu Gadisa ◽  
Esayas Tadesse Gebremariam ◽  
Getnet Yimer Ali

Abstract Background Breast cancer is the most common cancer among women and it affects quality of life of those women. So far, the two most frequently used tools for assessing health related quality of life in breast cancer patients, EORTC QLQ-C30 and EORTC QLQ-BR23 modules, were not validated in Ethiopia. Hence, the present study aimed to assess the psychometric properties of the tools among Ethiopian breast cancer patients. Methods Institutional based longitudinal study was conducted from January 1 to May 1, 2017 GC at only nationwide oncology center, Tikur Anbessa Specialized Hospital (TASH), Addis Ababa, Ethiopia. A total of 146 patients who visited the facility during that period, with no missing quality of life data, were selected for analysis. The psychometric properties of the EORTC QLQ-C30 and EORTC QLQ-BR23 were evaluated in terms of reliability, convergent, divergent, construct and clinical validity using SPSS version 22. Results Satisfactory internal consistency reliability (Cronbach’s α coefficients > 0.7) was confirmed, except for cognitive function (α = 0.516) of EORTC QLQ-C30 and body image (α = 0.510) of EORTC QLQ-BR23. Multiple-trait scaling analysis demonstrated a good convergent and divergent validity. No scaling errors were observed. Most items in EORTC QLQ-BR23 possessed a weak or no correlation with its own dimension in EORTC QLQ-C30 (r < 0.4) except with some of symptom scales. A statistically significant chemotherapy induced quality of life scores changes (P ≤ 0.05) were observed in all dimensions of both instruments between baseline and the end of first cycle chemotherapy, except for body image (P = 0.985) and sexual enjoyment (P = 0.817) of EORTC QLQ-BR23, indicating clinical validity. Conclusion Amharic version of the EORTC QLQ-C30 and EORTC QLQ-BR23 modules are valid and adequately reliable tool and can be used for clinical and epidemiological cancer researches to study the health related quality of life (HRQoL) of women with breast cancer in Ethiopia.


2016 ◽  
Vol 22 (4) ◽  
pp. 473-475 ◽  
Author(s):  
Eija Roine ◽  
Carl Blomqvist ◽  
Pirkko-Liisa Kellokumpu-Lehtinen ◽  
Harri Sintonen ◽  
Tiina Saarto

Sign in / Sign up

Export Citation Format

Share Document